EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.-I.
Right arrow Articles by Yoshikawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.-I.
Right arrow Articles by Yoshikawa, T.
Experimental Biology and Medicine 230:281-287 (2005)
© 2005 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Protective Role of Urinary Trypsin Inhibitor in Acute Lung Injury Induced by Lipopolysaccharide

Ken-Ichiro Inoue*,{dagger}, Hirohisa Takano*,{dagger},1, Rie Yanagisawa*, Miho Sakurai*, Akinori Shimada{ddagger}, Shin Yoshino§, Hiroyuki Sato|| and Toshikazu Yoshikawa{dagger}

* Inhalation Toxicology and Pathophysiology Research Team, National Institute for Environmental Studies, Tsukuba, Japan; {dagger} Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan; {ddagger} Department of Veterinary Pathology, Faculty of Agriculture, Tottori University, Tottori, Japan; § Department of Pharmacology, Kobe Pharmaceutical University, Kobe, Japan; and || Research Center, Mochida Pharmaceutical Company, Ltd., Mochida, Japan

To whom requests for reprints should be addressed at 1 Inhalation Toxicology and Pathophysiology Research Team, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, 305-0053, Japan. E-mail: htakano{at}nies.go.jp

Urinary trypsin inhibitor (UTI), a serine protease inhibitor, has been widely used as a drug for patients with acute inflammatory disorders such as disseminated intravascular coagulation, shock, and pancreatitis. However, direct contribution of UTI to inflammatory diseases has not been established. The present study analyzed acute inflammatory lung injury induced by lipopolysaccharide (LPS) in UTI-deficient (–/–) mice and corresponding wild-type (WT) mice. UTI (–/–) and WT mice were treated intratracheally with vehicle or LPS (125 µg/kg). The cellular profile of bronchoalveolar lavage fluid, lung water content, histology, and expression of proinflammatory molecules in the lung were evaluated. After LPS challenge, both genotypes of mice revealed neutrophilic lung inflammation and pulmonary edema. UTI (–/–) mice, however, showed more prominent infiltration of inflammatory cells and edema than WT mice. After LPS challenge in both genotypes of mice, the lung levels of mRNA and/or protein expression of interleukin-1ß, macrophage inflammatory protein-1{alpha}, macrophage chemoattractant protein-1, keratinocyte chemoattractant, and intercellular adhesion molecule-1 (ICAM-1) were elevated in both groups, but to a greater extent in UTI (–/–) mice than in WT mice. These results suggest that UTI protects against acute lung injury induced by bacterial endotoxin, at least partly, through the inhibition of the enhanced local expression of proinflammatory cytokines, chemokines, and ICAM-1.

Key Words: urinary trypsin inhibitor • lipopolysaccharide • acute lung injury • cytokines • chemokines • intercellular adhesion molecule




This article has been cited by other articles:


Home page
ChestHome page
K.-i. Inoue, H. Takano, T. Yoshikawa, and J.H.J. Vernooy
Protease-Antiprotease Imbalance in Inflammatory Diseases in the Lung
Chest, August 1, 2005; 128(2): 1069 - 1069.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Experimental Biology and Medicine.